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ARTICLE
Type and Level of RMRP Functional Impairment Predicts
Phenotype in the Cartilage Hair Hypoplasia–Anauxetic Dysplasia
Spectrum
Christian T. Thiel, Geert Mortier, Ilkka Kaitila, Andre´ Reis, and Anita Rauch
Mutations in the RMRP gene lead to a wide spectrum of autosomal recessive skeletal dysplasias, ranging from the milder
phenotypes metaphyseal dysplasia without hypotrichosis and cartilage hair hypoplasia (CHH) to the severe anauxetic
dysplasia (AD). This clinical spectrum includes different degrees of short stature, hair hypoplasia, defective erythrogenesis,
and immunodeﬁciency. The RMRP gene encodes the untranslated RNA component of the mitochondrial RNA–processing
ribonuclease, RNase MRP. We recently demonstrated that mutations may affect both messenger RNA (mRNA) and ri-
bosomal RNA (rRNA) cleavage and thus cell-cycle regulation and protein synthesis. To investigate the genotype-phenotype
correlation, we analyzed the position and the functional effect of 13 mutations in patients with variable features of the
CHH-AD spectrum. Those at the end of the spectrum include a novel patient with anauxetic dysplasia whowas compound
heterozygous for the null mutation g.254_263delCTCAGCGCGG and the mutation g.195CrT, which was previously
described in patients with milder phenotypes. Mapping of nucleotide conservation to the two-dimensional structure of
the RMRP gene revealed that disease-causing mutations either affect evolutionarily conserved nucleotides or are likely
to alter secondary structure through mispairing in stem regions. In vitro testing of RNase MRP multiprotein-speciﬁc
mRNA and rRNA cleavage of different mutations revealed a strong correlation between the decrease in rRNA cleavage
in ribosomal assembly and the degree of bone dysplasia, whereas reducedmRNA cleavage, and thus cell-cycle impairment,
predicts the presence of hair hypoplasia, immunodeﬁciency, and hematological abnormalities and thus increased cancer
risk.
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The regulation of cell growth and division is not only
essential for normal stature but is also linked to further
conditions promoted by impaired cell-growth regulation,
such as cancer. Mutations in the RMRP gene lead to a wide
spectrum of autosomal recessive skeletal dysplasias with
different degrees of short stature, but also variably in-
cluding hypotrichosis, hematological abnormalities, im-
munodeﬁciency, and joint laxity. Although short stature
with metaphyseal dysplasia is a hallmark of the whole
spectrum—ranging from the milder phenotypes meta-
physeal dysplasia without hypotrichosis (MDWH [MIM
250460]) and cartilage hair hypoplasia (CHH [MIM
250250]) to the severe anauxetic dysplasia (AD [MIM
607095])1—Hirschsprung disease, immunodeﬁciency, he-
matological abnormalities, and malignancies have been
reported only in patients with CHH. The clinical classi-
ﬁcation is based mainly on the degree of short stature and
radiographic characteristics, consisting of mild metaphy-
seal dysplasia in MDWH, moderate metaphyseal dysplasia
in CHH, and severe spondyloepimetaphyseal dysplasia in
AD. In contrast to AD, the vertebral bodies in MDWH and
CHH are mildly affected, the pelvic appearance is normal,
and the epiphyses are usually only mildly affected (cone-
shaped phalangeal epiphyses in CHH). The growth plate
in AD is severely distorted, with few disseminated chon-
drocytes, almost no columnization, and highly irregular
osteochondral ossiﬁcation.2 The lack of correlation be-
tween the severity of skeletal manifestations and the oc-
currence of extraskeletal anomalies is a striking observa-
tion that presently is without explanation.3
The RMRP gene is transcribed by RNA polymerase III
and encodes the untranslated RNA component of the mi-
tochondrial RNA–processing ribonuclease RNase MRP,
which is involved in ribosome assembly and cell-cycle
regulation.1,4–6 Various mutations have been described to
date. Apart from the founder mutation g.70ArG, which
is present in 92% of Finnish and 48% of non-Finnish pa-
tients with CHH, a total of 25 insertions or duplications
between the TATA box and the transcription start site and
162 other mutations within the RMRP gene have been
identiﬁed in patients with phenotypes in the CHH-AD
spectrum (table 1).1,3,7–16 We recently showed the ﬁrst evi-
dence of a genotype-phenotype correlation by demon-
strating that the CHH founder mutation affects ribosome
assembly and cell-cycle regulation intermediately,whereas
AD mutations severely affect ribosomal assembly only.1 To
further investigate genotype-phenotype correlations, we
now analyze the functional effect of 13 mutations in pa-
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Table 1. Overview of Known RMRP Mutations, SNPs, and
Other Variants
RMRP Alteration Nationality
RMRP mutation:
g.26_5dupTACTACTCTGTGAAGCTGAGAA7 American
g.25_11dupACTACTCTGTGAAGC7 American
g.25_11tripACTACTCTGTGAAGC3,8,9 Swiss, English, Turkish
g.25_10tripACTACTCTGTGAAGCT3 Italian
g.25_6dupACTACTCTGTGAAGCTGAGA7 Belgium
g.25_5dupACTACTCTGTGAAGCTGAGGA3 German
g.24_15dupCTACTCTGTG7 American
g.23_15dupTACTCTGTG3 French
g.23_14dupTACTCTGTGA3,8,9 Finnish, French
g.23_4dupTACTCTGTGAAGCTGAGGAC7 German
g.22_10dupACTCTGTGAAGCT3 French
g.21_1dupCTCTGTGAAGCTGAGGACGTG7 American
g.20_14dupTCTGTGA3,7,8 American
g.20_4dupTCTGTGAAGCTGAGGAC3,9–11 English, Japan, Swiss
g.16_7dupTGAAGCTGAG8 French
g.16_1insCTCTGTGAAGCTGAGG10 Japan
g.15_2dupGAAGCTGAGGACGTGGT10,11 Japan
g.14_7dupAAGCTGAG8 Mexican
g.14_3dupAAGCTGAGGACG12 Swiss/Danish
g.14_1dupAAGCTGAGGACGTG8 American
g.13_1dupAGCTGAGGACGTG8 American
g.8_1dupAGGACGTG3 Canadian
g.7_3dupGGACGTGGTT8 Brazilian
g.7_1insCCTGAG9 Finnish, German
g.4_6insGGACGTGGTT8 American
g.4CrT3,8,13 English, German,
Spanish
g.9TrC7 German
g.14GrT7 American
g.14GrA1 German
g.35CrT3 French
g.40GrA3 Dutch
g.45_53dupTGTTCCTCC3 Dutch
g.57_64insTTCCGCCT8 French
g.63CrT3,8,14 Australian, Dutch
g.64TrC3 Italian
g.64TrA15 Chinese
g.70ArG3,7–9,12 Variousa
g.79GrA8 American
g.79GrT15 Chinese
g.80GrA7 American
g.89CrG7 American
g.90_91AGrGC1 German
g.91GrA7 Belgium
g.93GrC3 Dutch
g.92_93insA3 Turkish
g.94_95delAG8,16 Amish, English
g.97GrA3,7 American
g.96_97dupTG3,8,9 Canadian, Turkish
g.101CrT7 Belgium
g.111_112insACTGTAGACATTCCT1 Jordanian
g.116ArG7 American
g.118ArG8 German
g.124CrT7 American
g.126CrT3,8 Arabian, Italian
g.127GrA3 Italian, Canadian
g.146GrA3,8 Chinese, French
g.146GrC3 Italian
g.152ArG8 Canadian
g.154GrT8 Finnish
g.168GrA10 Japan
g.180GrA7,8 Mexican, American
g.182GrC8 Dutch, English
g.182GrA10,11 Japan
g.182GrT3,7 German
g.193GrA3,8,9 English, Canadian
g.195CrT3,7,8,12 (present article) Variousb
g.194_195insT7,14 American
(continued)
Table 1. (continued)
RMRP Alteration Nationality
g.211CrG7,8 Variousc
g.213CrG3,7 German
g.214ArT8 German
g.217CrT10 Japan
g.218ArG10,11 Japan
g.220TrC3 German, Italian
g.230CrT8 Polish
g.236ArG8 American
g.238CrT3,8,12 Variousd
g.242ArG3,8 Canadian, Brazilian
g.243CrT8 Canadian
g.244GrA3 German
g.248CrT3 Canadian
g.254CrG1 German
g.254_263delCTCAGCGCGG (present article) Spanish/Mexican
g.261CrT3,8 Israeli, Trinidad
g.262GrC7 German
g.262GrT8,9 Finnish
g.264CrA8 Austrian
RMRP polymorphism:
g.58TrC3,11,12 …
g.56ArG1,3,11,12 …
g.48CrA1,3,11,12 …
g.6GrA1,3,11,12 …
g.127GrC3,7 …
g.156GrC1,3,11,12 …
g.177CrT1,3,11,12 …
g.*7 (272)TrC7,12 …
g.*9 (274)TrC1,3,11,12 …
RMRP variant:
g.24CrG12 …
g.36TrG11 …
g.55_56InsC11 …
g.57_58InsA12 …
g.162CrT11 …
g.172CrT11 …
g.250CrT12 …
NOTE.—Mutations analyzed in the functional assays in this study are
in bold font. Mutations observed in patients with AD are in italics.
a Finnish, Swiss/Danish, American, Canadian, Dutch, Turkish, English,
Amish, Australian, French, German, Brazilian.
b Swiss/Danish, Israeli, Brazilian, Spanish/French.
c Finnish, American, Polish, German.
d Austrian, Israeli, American, Australian.
tients with variable features in the CHH-AD spectrum, in-
cluding a novel patient with AD.
Material and Methods
This study was approved by the ethical review board of the med-
ical faculty of the Friedrich-Alexander University of Erlangen-
Nuremberg, Germany.
Novel Patient with AD
This 11-year-old girl (ﬁg. 1a), the ﬁrst child of nonconsanguin-
eous, healthy parents, was born at 40.5 wk with a body length
of 39 cm (!5 SD), a weight of 3,000 g (!1 SD), and a normal
head circumference (mean for gestational age). Short limbs were
noted on prenatal ultrasound at ∼17 wk of gestation. The post-
natal course was uneventful. She had a normal psychomotor de-
velopment. She underwent an adenoidectomy at age 7 years and,
1 year later, had a supernumerary tooth removed. Hermajormed-
ical problem was related to her short stature and severe growth
failure. She progressively developed scoliosis and joint pain in
the lower limbs. At age 9 years, her height was 83 cm (8 SD),
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Figure 1. Clinical and radiographic features of the novel patient
with the AD phenotype. A, Female patient at age 10 years, showing
severe disproportionate short stature. B and D, Radiographs of the
axial and appendicular skeleton at age 8 years. The spine is ab-
normal, with thoracolumbar scoliosis and foreshortened vertebral
bodies (on lateral ﬁlm) showing anterior and posterior scalloping
at the lumbar level. The end plates are slightly convex. The pelvis
shows coxa vara with dysplastic femoral heads and severe short-
ening of the femoral necks. The femur, tibia, and ﬁbula are short,
with severe metaphyseal changes. The knee epiphyses are small
and ﬂattened. There is mesomelic shortening in the upper limbs.
C, Hand radiograph taken at age 9 years. Metaphyseal changes are
apparent in the wrists, with shortening of the distal ulna and ulnar
kinking of the distal radius. The phalanges and metacarpals are
short and broad (bullet-shaped middle phalanges), with small
epiphyses already attached to the metaphyses.
weight was 16.6 kg (4 SD), and head circumference was 52 cm
(mean for age). Clinical evaluation at age 10 years revealed a
normal face, normal hair, and disproportionate short stature,with
short limbs and severe thoracolumbar scoliosis with right-sided
gibbus. She was not able to fully extend her elbows but did show
pronounced ligamentous laxity in the ﬁngers and toes and also
in her knees. Her hands and feet were very short.
Evaluation of the radiographs taken at age ∼8–9 years revealed
a spondyloepimetaphyseal involvement. All tubular bones were
shortened, with widened and irregular metaphyses and rather
small epiphyses (ﬁg. 1b). For most of these bones, the epiphyses
were already attached to the corresponding metaphyses, indicat-
ing a premature fusion of the growth plate. The hands showed
brachydactyly with short and broad phalanges and metacarpals
(ﬁg. 1c). The spine did not show platyspondyly but rather fore-
shortened vertebral bodies with posterior scalloping. The pelvis
revealed severe coxa vara with short femoral necks and dysplastic
capital femoral epiphyses.
After receiving informed consent, we obtained peripheral blood
samples from her and her parents. Sequencing of the whole
known promoter and transcript region of the RMRP gene was
performed as described elsewhere1 and revealed two heterozygous
mutations, g.195CrT and g.254_263delCTCAGCGCGG. The dif-
ferent parental origin of these mutations conﬁrmed compound
heterozygosity. Both mutations affect evolutionarily highly con-
served regions and were absent in 378 control chromosomes.
In addition, we identiﬁed the three known frequent SNPs:
g.58TrC and g.48CrA, which were both heterozygous, and
g.*9TrC, which was homozygous.
Phenotype Scoring
Since most mutations have been described in a compound het-
erozygous state with other mutations, we scored the phenotype
of patients whose case was published with sufﬁcient clinical data
and who harbored at least 1 of the 13 mutations analyzed with
respect to degree of bone dysplasia, hair hypoplasia, and addi-
tional features, such as immune deﬁciency and hematological
abnormalities, and we calculated an average score for each trait
in each mutation (table 2). Mild bone dysplasia was identiﬁed by
the shortening of bones and recognizable metaphyseal changes;
intermediate bone dysplasia was identiﬁed by shortened long
bones associated with severe, pronounced metaphyseal changes
and phalangeal epiphyseal (cone-shaped) changes. Additional in-
volvement of the spine and severe epiphyseal changes were the
hallmarks of severe bone dysplasia. Hair hypoplasia with thin,
often lightly colored hair was scored as present or not. The clas-
siﬁcation of immunodeﬁciency and hematological abnormalities
was scored as none when no signs of immunodeﬁciency (e.g.,
recurrent infections) were present and hematological parame-
ters—for example, red and white blood cell counts—were within
the normal age-related range, was scored mild when the patients
showed recurrent infections or mild anemia and/or leukopenia
that did not need treatment, was scored intermediatewhen severe
immunodeﬁciency or severe anemia and/or leukopenia were pre-
sent, and was scored severe when patients had severe immuno-
deﬁciency with opportunistic infections and severe anemia and/
or leukopenia leading to bone marrow transplantation.
Multiple Sequence Alignment of the RMRP Gene Region
We analyzed evolutionary conservation by comparing thehuman
RMRP gene against the orthologous sequences of mouse (Mus
Table 2. Phenotype Scoring in Mutations Selected for Functional Studies
Selected Mutation
and Second Allele
Bone
Dysplasia
Hair
Hypoplasia
Immunodeﬁciency
and Hematological
Abnormalities Reference
g.195CrT:
g.14_3dupAAGCTGAGGACG 1 0 1 Bonafe et al.12
g.146GrC 2 0 0 Bonafe et al.3
g.220TrC 2 1 3 Bonafe et al.3
g.14_3dupAAGCTGAGGACG 2 0 0 Bonafe et al.3
g.70ArG 1 0 0 Bonafe et al.3
g.254_263delCTCAGGCGCGG 3 0 0 Present article
Mean score 1.83 .17 .67
g.63CrT:
g.70ArG 2 0 2 Ridanpaa et al.8
g.195insT 2 1 3 Kuijpers et al.14
g.4CrT 1 1 0 Bonafe et al.3
g.70ArG 2 0 0 Bonafe et al.3
g.23_14dupTACTCTGTGA 1 0 1 Bonafe et al.3
g.70ArG 1 0 1 Bonafe et al.3
Mean score 1.5 .33 1.17
g.70ArG:
g.23_15dupTACTCTGTG 2 0 1 Bonafe et al.3
g.8_1dupAGGACGTG 1 1 2 Bonafe et al.3
g.96_97dupTG 2 0 0 Bonafe et al.3
g.20_14dupTCTGTGA 2 0 2 Bonafe et al.3
g.63CrT 2 0 2 Ridanpaa et al.8
g.63CrT 2 0 0 Bonafe et al.3
g.70ArG 2 1 1 Bonafe et al.3
g.70ArG 2 1 0 Bonafe et al.3
g.63CrT 1 0 1 Bonafe et al.3
g.238CrT 1 0 0 Bonafe et al.3
g.70ArG 2 0 0 Bonafe et al.3
g.70ArG 1 1 0 Bonafe et al.3
g.35CrT 1 1 2 Bonafe et al.3
g.195CrT 1 0 0 Bonafe et al.3
g.70ArG 1 0 0 Bonafe et al.3
g.238CrT 1 0 0 Bonafe et al.3
g.20_14dupTCTGTGA 2 1 1 Hermanns et al.7
g.70ArG 2 1 0 Hermanns et al.7
g.70ArG 2 1 1 Hermanns et al.7
g.70ArG 2 0 0 Hermanns et al.7
g.70ArG 2 1 2 Hermanns et al.7
Mean score 1.62 .43 .71
g.96_97dupTG:
g.70ArG 2 0 0 Bonafe et al.3
g.25_11tripACTACTCT 2 0 2 Bonafe et al.3
Mean score 2 0 1
g.126CrT:
g.64TrC 2 0 0 Bonafe et al.3
g.92_93insA 1 0 0 Bonafe et al.3
g.126CrT 2 0 0 Ridanpaa et al.8
Mean score 1.67 0 0
g.146GrA:
g.195CrT 2 0 0 Bonafe et al.3
g.22_10dupACTCTGTGAAGCT 1 1 2 Bonafe et al.3
g.146GrA 1 0 0 Ridanpaa et al.8
Mean score 1.33 .33 .67
g.4CrT:
g.25_10tripACTACTCTGTGAAGCT 1 0 1 Bonafe et al.3
g.20_4dupTCTGTGAAGCTGAGGAC 1 0 3 Bonafe et al.3
g.220TrC 2 0 1 Bonafe et al.3
g.63CrT 1 1 0 Bonafe et al.3
g.238CrT 1 0 2 Bonafe et al.3
g.25_11dupACTACTCTGTGAAGCTGAGAA 1 0 2 Munoz-Robles et al.13
Mean score 1.17 .17 1.5
g.220TrC:
g.195CrT 2 1 3 Bonafe et al.3
g.4CrT 2 0 1 Bonafe et al.3
Mean score 2 .5 2
g.248CrT:
g.127GrA 1 1 3 Bonafe et al.3
Score 1 1 3
g.261CrT:
g.261CrT 2 0 0 Bonafe et al.3
Score 2 0 0
NOTE.—For bone dysplasia, 1 p mild; 2 p intermediate; 3 p severe. For hair hypoplasia, 0 p absent; 1 p present. For
immunodeﬁciency and hematological abnormalities, 0 p none; 1 p mild; 2 p intermediate; 3 p severe.
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musculus), rat (Rattus norvegicus), rabbit (Oryctolagus cuniculus),
dog (Canis familiaris), armadillo (Dasypus novemcinctus), elephant
(Loxodonta africana), opossum (Monodelphis domestica), and pipid
frog (Xenopus tropicalis) from the National Center for Biotech-
nology Information (NCBI) and the University of California–
Santa Cruz (UCSC Genome Browser) databases, with use of the
ClustalW Multiple Sequence Alignment algorithm (Baylor Col-
lege of Medicine) and AlignX of the Vector NTI Suite 6.0
(InforMax). Evolutionary conservationwas consideredhighwhen
all species showed the same nucleotide, was signiﬁcant when at
least eight of nine species had the same nucleotide, and wasmod-
erate when more than six species had a conserved nucleotide at
the position (ﬁg. 2a). The degree of conservation and the position
of sequence alterations were then transferred to the two-dimen-
sional model of the RMRP transcript (ﬁg. 2b).
RNA Analysis
The ratio of the mRNA levels of the mutations g.254_263del-
CTCAGCGCGG and g.195CrT, detected in our novel patient,was
analyzed by sequencing of the RT-PCR products from cDNA syn-
thesized using Superscript II Reverse Transcriptase Kit with ran-
dom hexamer primers (Invitrogen) from RNA extracted from a
lymphoblastoid cell line of the patient.
Analysis of Mutant RMRP Constructs and Real-Time PCR
Assays
To identify the inﬂuence of differentmutations on ribosomalRNA
(rRNA) and mRNA processing and the role of the involved RMRP
domains, we selected 13 mutations distributed over the different
base-pairing stem regions and RNA-protein–binding domains
for which detailed clinical information was available. This in-
cluded three AD mutations (g.111_112insACTGTAGACATTCCT,
g.90_91AGrGC, and g.254CrG), nine mutations associated
with milder phenotypes (g.63CrT, g.70ArG, g.96_97dupTG,
g.126CrT, g.146GrA, g.4CrT, g.220TrC, g.248CrT, and
g.261CrT), and the g.195CrT mutation, which occurred in our
novel patient with AD but was previously described in association
with CHH. After PCR ampliﬁcation, the RMRP wild type was
cloned into the pcDNA3.1 vector with the Directional TOPO Ex-
pression Kit vector (Invitrogen). Each mutation was inserted in
a different RMRP wild-type clone by use of the Quik-Change site-
directed mutagenesis kit (Strategene), in accordance with the
manufacturer’s instructions.
Transient transfection of normal human ﬁbroblasts with each
of the different RMRP constructs was performed as described else-
where.1 After RNA and DNA extraction with the TRIzol Reagent
(Invitrogen), RMRP, CCNB2, 5.8S rRNA, and ITS-1–bound 5.8S
rRNA expression levels were quantiﬁed by real-time PCR on a
7900HT (Applied Biosystems) with the QuantiTect Probe RT-PCR
Kit (Qiagen). Results were normalized against the mean of four
endogeneous controls (b-2-microglobulin, b-actin, hypoxanthine
phosphoribosyltransferase 1, and RNA polymerase II). Relative
cell count was measured by targeting albumin genomic DNA lev-
els. The assay for each sample was performed in 384-well plates
with a ﬁnal volume of 20 ml each. Expression levels were calcu-
lated using the DDCt method and were normalized to the ex-
pression levels in cells transfected with wild-type RMRP, which
were set to 1. mRNA cleavage activity was calculated as the inverse
relative increase of CCNB2 mRNA level. rRNA cleavage activity
was expressed as the ratio of levels of cleaved to uncleaved 5.8S
rRNA.
Results
Conservation of the RMRP Gene Region and Mutational
Position
In most parts, conservation of the transcribed region was
organized in blocks of high-to-signiﬁcant conservation,
predicting sites of base-pairing stems or RNA-DNA inter-
action (ﬁg. 2a). Interestingly, two blocks of continuous
high conservation comprise the regions 61–81 and 241–
258, which provide a major tertiary interaction to form
the so-called LRI-1 element (ﬁg. 2a), the central core of
the functional domain 1.19 The distance between the TATA
box and the transcription start site, which is important
for maintaining transcription levels, showed a conserved
length of 24–26 bp. Of the 46 known putative pathoge-
netic single-nucleotide mutations, 33 were located in
highly conserved regions, 8 within signiﬁcantly conserved
regions, and 2 in moderately conserved regions. In con-
trast, ﬁve putative polymorphisms within the RMRP tran-
script resided in not conserved or moderately conserved
regions. Mapping of the conservation information to the
two-dimensional structure of the RMRP transcript showed
highly conserved stem and loop structures within the P1,
P2, P3, P8, P9, and P12 domains (ﬁg. 2b). Conservation is
exceptionally high within regions of base-pairing stems
and sites of proposed RNA-protein interaction; hence,mu-
tations predominantly affect these regions. Four muta-
tions (g.116ArG, g.118ArG, g.126CrT, and g.220TrC)
were situated in evolutionarily nonconserved regions.
Three of these mutations (g.118ArG, g.126CrT, and
g.220TrC) have an impact on interaction with the cor-
responding nucleotide within conserved stem structures.
The mutation at position 116, which also affects a non-
conserved nucleotide, seems to not be part of a stem struc-
ture, but this position might be necessary for RNA-protein
interaction.
Sequencing of the RMRP RT-PCR product of our novel
patient showed absence of detectable levels of the mu-
tation allele g.254_263delCTCAGCGCGG, whereas the
g.195CrT allele was present (data not shown). The ﬁrst
of these mutations and the g.14GrA mutation, identi-
ﬁed as compound heterozygous in another patient with
AD,1 are likely to result in an unstable RNA and there-
fore represent null alleles. Hence, the mutations g.254_
263delCTCAGCGCGG and g.14GrA were not analyzed
in the functional assays.Mutations increasing the distance
between the TATA box and the transcription start site,
which are presumed to decrease the RMRP transcription
level, were observed only as compound heterozygous in
patients with CHH or MDWH.
Genotype-Phenotype Correlation
Comparison of phenotype scores and rRNA and mRNA
cleavage activities revealed signiﬁcant negative correla-
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tions between the degree of bone dysplasia and rRNA
cleavage activity (correlation coefﬁcient ;Rp 0.8346
), between the degree of immunodeﬁciencyPp .0008
or hematological abnormalities and mRNA cleavage ac-
tivity ( ; ), and between the inci-Rp0.8429 Pp .0007
dence of hair hypoplasia and mRNA cleavage activity
( ; ). Compound heterozygosity ofRp0.8115 Pp .001
mutations g.111_112insACTGTAGACATTCCT, g.90_
91AGrGC, and g.254CrG results in AD that pre-
sents with the highest degree of bone dysplasia and
without any additional obvious features, such as hair hy-
poplasia, immunodeﬁciency, or hematological abnormal-
ities, in the affected patients (table 2 and ﬁg. 3a and 3b).
Mutations g.126CrT and g.261CrT were also associated,
in most cases, with bone dysplasia only. No hair hypo-
plasia but bone dysplasia and different degrees of addi-
tional features were present in patients compound het-
erozygous for mutations g.4CrT, g.96_97dupTG, and
g.146GrA. Mutations g.63CrT, g.70ArG, g.220TrC, and
g.248CrT were identiﬁed as compound heterozygous in
patients with bone dysplasia, hair hypoplasia, and dif-
ferent degrees of additional features. The mutation
g.195CrT, identiﬁed as compound heterozygous with
a null mutation in our novel patient with AD, was
described as compound heterozygous with the mutations
g.20_14dupTCTGTGA, g.16_7dupTGAAGCTGAG,
g.20_4dupTCTGTGAAGCTGAGGAC, g.64TrC,
g.146GrC, g.220TrC, and g.242ArG in patients with an
intermediate level of bone dysplasia,mild hair hypoplasia,
and mild additional features or who were given the clas-
siﬁcation of CHH without further details.3,7,8,12
Cleavage Activity in Mutant RMRP Constructs
In accordance with our previous ﬁndings,1 human ﬁbro-
blast cultures transiently transfected with the RMRP wild-
type construct showed an increase in endonucleolytic
cleavage activity at the ITS-1–5.8S rRNA junction site,
whereas cells transfected with the mutant constructs pre-
sented with variably impaired cleavage activity repre-
sented by the decrease in the ratio of cleaved to uncleaved
5.8S rRNA when normalized to the wild-type transfected
cells (ﬁg. 3a). The decrease in cleavage activity was most
pronounced in cells transfected with the AD mutations
g.111_112insACGTAGACATTCCT and g.90_91AGrGC.
Mutations g.254CrG and g.195CrT, which occurred as
compound heterozygotes with g.90_91AGrGC and a null
allele in patients with the severe skeletal dysplasia phe-
notype AD, led to a decrease in cleavage activity in the
intermediate range. Only mild impairment was observed
for the mutations g.148GrA, g.248CrT, and g.70ArG.
We also showed elsewhere that cells overexpressing
RMRP wild-type constructs presented with a decrease
in cyclin B2 mRNA correlating with an increase in B2
mRNA cleavage activity.1 The most signiﬁcant impair-
ment of cyclin B2 mRNA cleavage was seen for the mu-
tations g.248CrT, g.70ArG, and g.63CrT (ﬁg. 3b).
The AD mutations g.111_112insACGTAGACATTCCT,
g.90_91AGrGC, and g.254CrG, as well as the mutations
g.126CrT and g.261CrT seen in milder phenotypes,
showed no signiﬁcant alteration compared with the wild
type. The mutation g.195CrT, associated with AD in our
novel patient but also with milder phenotypes in com-
pound heterozygosity with other mutations, showed a
mild degree of cyclin B2 mRNA cleavage activity.
Discussion
Mutations of the RMRP gene can be primarily classiﬁed
into alterations within the distance between the TATA box
and the transcription start site (insertions, duplications,
and triplications) and mutations within the RMRP tran-
script. Although the ﬁrst group reduces the RMRP tran-
scription level and should therefore be considered hypo-
morphic alleles,9 the second group previously showed no
obvious genotype-phenotype correlation. Because the
RMRP gene is not translated into protein, even the dis-
tinction between rare variants and mutations has been
difﬁcult, especially since there was no strict correlation of
affected nucleotides with evolutionary conservation
among mammals.3 According to our alignment data in
nine phylogenetically diverse species, all but four known
pathogenic mutations are located within highly or mod-
erately conserved regions. In contrast, the known com-
mon polymorphisms g.156GrC and g.177CrT are posi-
tioned within nonconserved areas. The same holds true
for rare, probably not disease-related variants g.36TrG,
g.55_56insC, g.57_58insA, and g.162CrT. The impact of
the other rare variants, g.172CrT and g.250CrT—which
affect a moderately and highly conserved nucleotide close
to an important interaction site between 72–79 bp and
243–249 bp, respectively—remains unknown.
To gain further insight into the genotype-phenotype
correlation, we mapped nucleotide conservation to the
recently conﬁrmed two-dimensional structure of the
RMRP transcript.4,19 It became obvious that highly con-
served regions are part of stem and loop regions assumed
to be important for the two-dimensional structure and
RNA-protein binding, respectively. g.118ArG, g.126CrT,
and g.220TrC, three of the four mutations not affecting
conserved nucleotides by sequence alignment, were part
of stem regions with high conservation of the type of
interacting bases that allow for base pairing in the sec-
ondary structure. Accordingly, 20 of 23 disease-causing
mutations within these stem structures are G/CrA/T, or
vice versa, substitutions. The transitions (C/GrG/C or A/
TrT/A) g.89CrG, g.213CrG, and g.214ArT, for which no
SNPs have been described yet, are part of RNA-protein–
binding domains and they might therefore alter pro-
tein-binding capacities. The mutations g.14GrA1 and
g.254_263delCTCAGCGCGG (the present article), both of
which are not detectable by RT-PCR and thus apparently
lead to mRNA instability, are located in the highly con-
Figure 2. A, Schematic drawing of RMRP (top) and degree of RMRP evolutionary conservation (bottom), categorized into four levels
by sequence alignment of nine species. The length between the TATA box and the transcription start site is conserved at 24–26 bp.
This distance is known to be important for proper binding of the RNA polymerase III transcription factor complex (TFIIIB) and is altered
by insertions, duplications, and triplications, leading to reduced transcription.9,17,18 SP1 p SP1 binding site; octamer p octamer
element; PSEp proximal sequence element. Nucleotides for which disease-related mutations have been published are in red; polymorphic
sites are in blue. B, Mapping of evolutionary conservation of RMRP nucleotides to its two-dimensional structure.4 Green indicates
moderately to highly conserved nucleotides. Nucleotides for which disease-related mutations have been published are boxed in red;
polymorphic sites are boxed in blue. Red arrows indicate insertion or deletion mutations; blue arrows indicate insertion or deletion
polymorphisms. Note that disease-related mutations, which do not affect conserved nucleotides, lead to mispairing in stem structures.
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served P1 and P2 domains, whichmight also be important
for the formation of the LRI-1 central core domain. The
strikingly different phenotype for mutations in the P8 do-
main can be explained by the fact that, in contrast to the
g.96_97dupTG mutation, the g.90_90AGrGC mutation
not only changes the base-pair composition of the stem
region but also affects the G of the GNRA tetraloop, the
RNA-protein–binding site of the P8 domain.1 The muta-
tion 96_97dupTG on the other side changes neither the
stem region nor the GNRA tetraloop but might also inﬂu-
ence the steric conformation of this loop, with only a
milder effect on the phenotype. In contrast, the SNPs are
located within nonconserved loop regions, affect stem
regions in which both interacting nucleotides are non-
conserved (g.156GrC and g.162CrT), or represent tran-
sitions within stem regions (g.127GrC, g.156GrC, and
g.162CrT). Notably, transitions at positions 127, 182, and
262 represent SNPs, whereas substitutions G/CrA/T, or
vice versa, have been associated with a disease phenotype.
To address the question of genotype-phenotype corre-
lation with respect to functional impairment of the ri-
bosomal assembly as a prerequisite for protein synthesis
and cell-cycle progression, we analyzed the effect of 13
different mutations on the phenotypic expression in cor-
relation with rRNA and mRNA processing. Whereas mu-
tations causing the severe AD skeletal phenotype were not
associated with nonskeletal features, mutations described
in patients with the milder skeletal phenotypes showed
variable additional features, such as hair hypoplasia, im-
munodeﬁciency, and hematological abnormalities (table
2 and ﬁg. 3a and 3b).
Because our ﬁrst results indicated a function of the
RNAse MRP complex in cleavage of 5.8S rRNA, as well as
cleavage of cyclin B2 mRNA, we measured the degree of
impairment of speciﬁc rRNA and mRNA cleavage activity
caused by the 13 chosen mutations. Our results showed
diminished rRNA cleavage for all mutations, which was
most pronounced in the AD mutations and was only
mildly to intermediately affected by the CHH andMDWH
mutations. The degree of decrease in rRNA cleavage thus
strongly correlated with the degree of bone dysplasia, as
ascertained by our phenotype scoring (ﬁg. 3a). We there-
fore conclude that the impairment of rRNA cleavage by
RMRP mutations is the leading cause of bone dysplasia in
patients with features in the CHH-AD spectrum.
In comparisons of the cyclin B2 mRNA cleavage activity
for the differentmutations, a signiﬁcant decrease inmRNA
cleavage activity was observed only for mutations asso-
ciated with the milder skeletal phenotypes. Because over-
expression of cyclin B2 leads to accumulation of cells in
late mitosis and contributes to chromosomal instabili-
ty,20–22 we assumed that diminished mRNA cleavage was
associated with susceptibility to cancer and proliferative
bone marrow dysfunctions, such as immunodeﬁciency
and anemia, as well as hair hypoplasia. Comparison of the
mRNA cleavage activity with these features revealed that
a decrease in mRNA cleavage activity indeed predicts the
presence of immunodeﬁciency and hematological abnor-
malities and increases the likelihood of hair hypoplasia
(ﬁg. 3b). Our results also indicate a predominant partici-
pation of the domains P1, P2, and P19, as well as P8, P9,
and P12, in the rRNA cleavage function, whereas parts of
the P3 and P4 domains seem to be involved mainly in
mRNA cleavage (ﬁg. 4). Thismight suggest respective func-
tions of the associated proteins of the RNAse MRP com-
plex. On the basis of the observed role of the domains P1,
P2, P19, P8, P9, and P12 in rRNA cleavage, the interacting
proteins hPOP1 and Rpp25 could also be involved in rRNA
cleavage, whereas the protein hPOP4 might be involved
in mRNA cleavage. Hence, these proteins could be can-
didates for mutational screening, in as-yet-unexplained
disorders of body and hair growth and bone marrow func-
tion, but further experimental support for this hypothesis
is needed.
However, the actual phenotype of patients with com-
pound heterozygous mutations might be quite variable,
depending on the functional impairment resulting
from the respective combination of mutations. Accord-
ingly, the novel patient with the severe AD skeletal
phenotype was compound heterozygous for the null
mutation g.254_263delCTCAGCGCGG and the moder-
ately impairing mutation g.195CrT, which was previ-
ously described in patients with milder phenotypes.
Those patients were compound heterozygous with in-
sertions and/or duplications in the promoter region
(g.20_14dupTCTGTGA, g.16_7dupTGAAGCTGAG,
and g.20_4dupTCTGTGAAGCTGAGGAC) or single-
nucleotide changes within the RMRP transcript (g.64TrC,
g.146GrC, g.220TrC, and g.242ArG), leading to mild-
to-moderate functional alterations only.3,12,7,8 Neverthe-
less, as in virtually every known genetic disorder, even the
same RMRP genotype may be associated with different de-
grees of phenotypic manifestations in a subset of patients,
probably depending on nonallelic modiﬁers.
In conclusion, we showed that the milder skeletal phe-
notypes are caused either by two mutations leading to
mild-to-intermediate functional alteration of mRNA and
rRNA cleavage or by compound heterozygosity with one
of the mutations leading to mild-to-intermediate func-
tional alteration and one allele reducing the transcription
level by alterations within the distance between the TATA
box and the transcription start site. In contrast, the more
severe skeletal phenotype of AD is caused either by two
mutations leading to intermediate-to-severe functional al-
teration of rRNA cleavage or by compound heterozygosity
of the mutations leading to intermediate-to-severe func-
tional alteration, with an allele leading to absence of the
respective mRNA. We also found a strong correlation be-
tween the decrease in rRNA cleavage and the degree of
bone dysplasia, whereas reduced mRNA cleavage and thus
cell-cycle impairment predicts the presence of immuno-
deﬁciency, hematological abnormalities, and, thus, in-
creased cancer risk, as well as increased likelihood of hair
hypoplasia.
Figure 3. Correlation of phenotype scores for mutations analyzed, with reference to degree of bone dysplasia, hair hypoplasia, and
immunodeﬁciency/hematological abnormalities. A, Results of 5.8S rRNA cleavage activity normalized to wild-type activity as a function
of ribosomal assembly in 13 mutations, compared with the respective skeletal phenotype score, revealing a signiﬁcant negative correlation
between degree of bone dysplasia and rRNA cleavage activity ( ; ). rRNA cleavage was most affected by the ADRp0.8346 Pp .0008
mutations g.111_112insACGTAGACATTCCT and g.90_91AGrGC. An intermediate effect was observed for the AD mutation g.254CrG;
mutation g.195CrT, identiﬁed in the new patient with AD as well as in patients with CHH and MDWH; and mutations g.126CrT,
g.220TrC, g.261CrT, g.4CrT, g.63CrT, and g.96_97dupTG, leading to the milder phenotypes. The least effect was seen for g.146GrA,
g.248CrT, and g.70ArG. Red columns represent AD mutations, yellow columns represent CHH and MDWH mutations, and orange columns
represent AD, CHH, and MDWH mutations. B, Results of mRNA cleavage activity normalized to wild-type activity as a function of cell-
cycle progression in 13 mutations, compared with the respective immunological/hematological phenotype score and the incidence of
hair hypoplasia. Notably, the presence of impaired mRNA cleavage activity strongly correlates with the immunological/hematological
phenotype and the likelihood of hair hypoplasia ( [ ] and [ ], respectively).Rp0.8429 Pp .0007 Rp0.8115 Pp .001
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Figure 4. Two-dimensional structure of the RNase MRP complex. The RMRP gene encodes the untranslated RNA component of the
mitochondrial RNA–processing ribonuclease. Nucleotides mutated in milder phenotypes are shaded yellow, those mutated in the severe
skeletal phenotype are shaded red, and the mutation observed in both milder and severe skeletal phenotypes is shaded orange. Recently,
it was shown that the proteins Rpp20, Rpp21, Rpp25, Rpp30, Rpp38, hPop1, and hPop4 interact directly with the RNA frame formed
by the RMRP transcript, whereas hPop5 and Rpp14 do not.4,23,24 Our results also indicate a predominant participation of the P1, P2,
and P19 domains, as well as the P8, P9, and P12 domains, in the rRNA cleavage function, whereas parts of the P3 and P4 domains
seem to be involved mainly in mRNA cleavage.
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